Skip to content
September 27, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation
  • Genomics and Precision Medicine

The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation

Sagoh September 27, 2026 7 minutes read
the-scientific-imperative-ashg-reaffirms-genetic-unity-amidst-rising-ideological-misinformation

ROCKVILLE, MD – In an era where the rapid advancement of genomic technology intersects with increasingly polarized social discourse, the American Society of Human Genetics (ASHG) has issued a definitive statement addressing the misuse of genetic science. On September 24, 2020, the organization—representing nearly 8,000 of the world’s leading geneticists, researchers, and clinicians—reiterated its foundational stance: there is no biological basis for racial hierarchy, and the perversion of genetic data to support white supremacy or eugenics is scientifically bankrupt.

As the preeminent professional membership organization for the field, the ASHG’s intervention marks a critical point in the ongoing struggle to protect the integrity of scientific inquiry from the encroachment of discriminatory ideologies.


The Core Scientific Consensus: One Humanity, One Species

At the heart of the ASHG’s statement is the biological reality that humans cannot be partitioned into discrete, biologically superior subcategories. For decades, modern genomics has dismantled the outdated and discredited concepts of "racial purity" or "genetic superiority."

The Fallacy of Biological Determinism

The ASHG asserts that attempting to categorize human populations into "good" or "bad" genetic cohorts is a fundamental misreading of evolutionary biology. Modern research confirms that the overwhelming majority of genetic variation exists within any given population, rather than between different geographic groups.

"Genetics demonstrates that humans cannot be divided into biologically distinct subcategories or races," noted Dr. Anthony Wynshaw-Boris, MD, PhD, President of the ASHG. The society emphasizes that genetic ancestry—while a useful tool for medical diagnostics and evolutionary mapping—does not provide a blueprint for social, intellectual, or moral hierarchies. When individuals attempt to cite genetics to justify systemic inequality, they are not practicing science; they are engaging in a distortion of data to suit political or racist agendas.


A Chronology of Responsibility: The Long Shadow of Misused Science

To understand why the ASHG felt compelled to issue this statement, one must examine the dark history of the field and the organization’s evolution toward social accountability.

The Historical Context (1900–1945)

In the early 20th century, the burgeoning field of genetics was hijacked by proponents of eugenics. These individuals argued that human traits were entirely inherited and that society could be "improved" through selective breeding and the elimination of those deemed "unfit." This pseudoscience directly fueled forced sterilization programs in the United States and provided the pseudoscientific veneer for the atrocities of the Holocaust in Nazi Germany.

The Turning Point (1948–2000)

Founded in 1948 in the immediate aftermath of the Second World War, the ASHG was born out of a global realization that the misuse of genetic knowledge could lead to catastrophic human rights violations. Throughout the late 20th century, the field underwent a "moral reckoning," as geneticists moved away from deterministic theories toward a focus on human commonality and the nuances of environmental interaction.

The 2018 Denunciation

The 2020 statement is a direct descendant of the ASHG’s 2018 landmark publication in The American Journal of Human Genetics, titled "ASHG Denounces Attempts to Link Genetics and White Supremacy." That document served as a clear line in the sand, explicitly condemning the rise of "race realism"—a movement that utilizes cherry-picked genetic studies to argue for the supremacy of certain groups over others. By 2020, the ASHG determined that the persistence of these narratives necessitated a renewed, public reaffirmation of their ethical principles.


Supporting Data: Why Environment Outweighs Determinism

One of the most persistent myths addressed by the ASHG is the idea that genetics is the sole, or even primary, determinant of human success and health outcomes.

The Multidimensionality of Human Potential

While genetics plays a role in physical traits and susceptibility to specific diseases, the ASHG points to a robust body of evidence indicating that environmental, economic, and educational factors are frequently more potent in determining individual life outcomes.

  • Social Determinants of Health: Wealth, access to healthcare, clean air, and nutritional stability are documented as primary drivers of life expectancy and health outcomes.
  • The Power of Environment: Studies in epigenetics and sociology show that developmental environments can profoundly influence cognitive development, masking or amplifying underlying genetic predispositions.
  • The "Good Gene" Myth: There is no factual evidence for "superior" genes. Biological fitness is inherently tied to context—a genetic trait that provides an advantage in one environment may be neutral or detrimental in another.

By ignoring these variables, proponents of genetic determinism ignore the structural inequities—such as systemic poverty, lack of educational opportunity, and institutionalized health disparities—that actually drive the differences in outcomes they claim to be "genetic."


Official Responses and the Call to Action

The ASHG’s position is not merely a critique; it is a call for systemic change within the scientific community and beyond. The organization advocates for a "dual-track" approach to policy and research.

Ethical Advancement of Genomic Medicine

The society remains deeply committed to the progress of precision medicine. By understanding the commonalities and the subtle variations in the human genome, researchers are currently improving the lives of hundreds of thousands of people. From targeted cancer therapies to the management of rare genetic disorders, the ethical application of genetics is a cornerstone of modern healthcare.

A Call for Societal Intervention

The ASHG leadership argues that if society truly wants to close the gap in human experience, we must look to the social structures that sustain inequality. The organization urges policymakers, educators, and the public to:

  1. Address systemic inequalities: Tackle the educational and economic disparities that prevent people from reaching their full potential.
  2. Combat misinformation: Support public education that clarifies the difference between valid genetic science and white supremacist rhetoric.
  3. Engage in ethical oversight: Ensure that the future of genomic technology is guarded by robust ethical frameworks to prevent the resurgence of eugenic policies.

Implications: The Future of Genetics in Society

The implications of this stance by the ASHG are profound. As genomic testing becomes more accessible to the public—through direct-to-consumer kits and widespread medical integration—the potential for misinterpretation grows.

Protecting the Public Trust

If the scientific community fails to speak out against the hijacking of their research, the public may lose trust in the legitimacy of genetics. By maintaining a firm ethical stance, the ASHG ensures that their field is viewed as a tool for healing rather than a tool for division.

The Responsibility of the Geneticist

Modern geneticists operate with the burden of history. They are not only tasked with the technical challenges of sequencing and analysis but also with the social responsibility of interpreting that data for the public. The ASHG’s 2020 statement emphasizes that the "neutrality" of the scientist is no longer an option. In a world where data can be weaponized, scientists must be vocal advocates for the truth.

Conclusion: Celebrating Our Common Heritage

Ultimately, the American Society of Human Genetics concludes that our biological diversity is something to be celebrated, not feared or hierarchized. Genetic variation is the foundation of our adaptability as a species, and our common heritage is the tie that binds us together. By focusing on the ethical application of research and addressing the true causes of societal inequality, the ASHG envisions a future where genetics contributes to "optimal life outcomes for all."

As the organization continues to advance the field through its annual meetings and the American Journal of Human Genetics, it remains dedicated to the belief that the most profound discovery in the history of human genetics is the undeniable fact of our shared humanity.


About the American Society of Human Genetics (ASHG)
Founded in 1948, the ASHG is the primary professional membership organization for human genetics specialists worldwide. Its membership of 8,000 includes researchers, academicians, clinicians, and genetic counselors. The Society provides a critical forum for sharing research, advocating for policy, and educating the global public on the ethical and accurate use of genetic science. For more information, visit www.ashg.org.

About the Author

Sagoh

Author

View All Posts

Post navigation

Previous: Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

Related Stories

from-classroom-curiosity-to-agricultural-breakthrough-the-rise-of-bruce-the-peanut-1
  • Genomics and Precision Medicine

From Classroom Curiosity to Agricultural Breakthrough: The Rise of "Bruce" the Peanut

Lina Hope September 26, 2026
the-genetic-revolution-how-the-broad-institute-is-rewriting-the-future-of-medicine
  • Genomics and Precision Medicine

The Genetic Revolution: How the Broad Institute is Rewriting the Future of Medicine

Siti Muinah September 26, 2026
bridging-the-gap-how-new-research-into-biobank-diversity-is-reshaping-genomic-equity
  • Genomics and Precision Medicine

Bridging the Gap: How New Research into Biobank Diversity is Reshaping Genomic Equity

Sagoh September 26, 2026

Recent Posts

  • The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation
  • Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis
  • Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy
  • Roche and Ionis Advance New Therapeutic Frontier in the Fight Against IgA Nephropathy
  • A Landmark Victory: NHS England Approves Enhertu for HER2-Low Metastatic Breast Cancer

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-scientific-imperative-ashg-reaffirms-genetic-unity-amidst-rising-ideological-misinformation
  • Genomics and Precision Medicine

The Scientific Imperative: ASHG Reaffirms Genetic Unity Amidst Rising Ideological Misinformation

Sagoh September 27, 2026
reclaiming-intimacy-navigating-sexual-health-after-a-breast-cancer-diagnosis-1
  • Survivorship and Post-Treatment

Reclaiming Intimacy: Navigating Sexual Health After a Breast Cancer Diagnosis

Suro Senen September 27, 2026
remigromig-shows-efficacy-in-dme-but-tolerability-concerns-loom-for-msds-novel-therapy
  • Medical Research and Clinical Trials

Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy

Jia Lissa September 27, 2026
roche-and-ionis-advance-new-therapeutic-frontier-in-the-fight-against-iga-nephropathy
  • Treatment Innovations

Roche and Ionis Advance New Therapeutic Frontier in the Fight Against IgA Nephropathy

Nana Wu September 27, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.